Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer
Authors
Keywords
-
Journal
DRUG DELIVERY
Volume 25, Issue 1, Pages 517-532
Publisher
Informa UK Limited
Online
2018-02-13
DOI
10.1080/10717544.2018.1435747
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood–brain barrier, and the transporting mechanism to glioma cells
- (2017) Chang Liu et al. International Journal of Nanomedicine
- Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model
- (2016) Masoumeh Zahmatkeshan et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid
- (2016) Shravan Kumar Sriraman et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Co-delivery of Doxorubicin and PSC 833 (Valspodar) by Stealth Nanoliposomes for Efficient Overcoming of Multidrug Resistance
- (2016) Elmira Bajelan et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Design of liposomal formulations for cell targeting
- (2015) Eugénia Nogueira et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Nanocarriers for cancer-targeted drug delivery
- (2015) Preeti Kumari et al. JOURNAL OF DRUG TARGETING
- Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: In vitro and in vivo evaluation
- (2014) Ankitkumar S. Jain et al. BIOMEDICINE & PHARMACOTHERAPY
- Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model
- (2014) Jia Lin et al. PLoS One
- A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy
- (2014) LI QIN et al. Oncology Letters
- The Significance of Transferrin Receptors in Oncology: the Development of Functional Nano-based Drug Delivery Systems
- (2014) Stephanie Tortorella et al. Current Drug Delivery
- Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models
- (2013) Anjali Apte et al. CANCER BIOLOGY & THERAPY
- Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer
- (2013) Swati Biswas et al. CANCER LETTERS
- Arginine-rich Peptides: Methods of Translocation Through Biological Membranes
- (2013) Shiroh Futaki et al. CURRENT PHARMACEUTICAL DESIGN
- Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity
- (2013) Swati Biswas et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- A simple way to enhance Doxil® therapy: Drug release from liposomes at the tumor site by amphiphilic block copolymer
- (2013) Yi Zhao et al. JOURNAL OF CONTROLLED RELEASE
- Nanotechnology in cancer therapy
- (2013) Burcu Aslan et al. JOURNAL OF DRUG TARGETING
- The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy
- (2013) Rupa R. Sawant et al. JOURNAL OF DRUG TARGETING
- Cholesterol Derivatives Based Charged Liposomes for Doxorubicin Delivery: Preparation, In Vitro and In Vivo Characterization
- (2013) Yu Nie et al. Theranostics
- Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes
- (2012) Alexander Koshkaryev et al. CANCER BIOLOGY & THERAPY
- Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition
- (2012) Alexander Koshkaryev et al. CANCER LETTERS
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The transferrin receptor and the targeted delivery of therapeutic agents against cancer
- (2011) Tracy R. Daniels et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Pegylated Liposomal Doxorubicin
- (2011) Sean T. Duggan et al. DRUGS
- Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery
- (2011) Ikramy A. Khalil et al. JOURNAL OF CONTROLLED RELEASE
- Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment
- (2009) Ayman El-Sayed et al. AAPS Journal
- Arginine-rich cell-penetrating peptides
- (2009) Nathan Schmidt et al. FEBS LETTERS
- Targeted delivery of doxorubicin using stealth liposomes modified with transferrin
- (2009) XueMing Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Intracellulartransduction using cell-penetrating peptides
- (2009) Rupa Sawant et al. Molecular BioSystems
- Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
- (2009) C. H. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery
- (2008) Vladimir P. Torchilin BIOPOLYMERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now